XML 31 R61.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Other Operating Expense Net (Restructuring Costs and Reserve Details) (Details) (USD $) | 3 Months Ended
--- | ---
Mar. 29, 2013 | Mar. 30, 2012
Restructuring Cost and Reserve [Line Items] |  |
Proceeds from sale of orthopaedic product lines | $ 1,768,000 | $ 0
Orthopaedic Facility Optimization [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Activities, Description | In 2010, the Company began updating its Indianapolis, IN facility to streamline operations, consolidate two buildings, increase capacity, further expand capabilities and reduce dependence on outside suppliers. This initiative was completed in 2011. In 2011, the Company began construction on an orthopaedic manufacturing facility in Fort Wayne, IN and transferred the manufacturing operations being performed at its Columbia City, IN facility into this new facility. This initiative was completed in 2012. During 2012, the Company transferred most functions performed at its facilities in Orvin and Corgemont, Switzerland into existing facilities in Fort Wayne, IN and Tijuana, Mexico. In connection with this consolidation, in 2012, the Company entered into an agreement to sell certain non-core Swiss orthopaedic product lines to an independent third party which included the inventory, machinery, equipment, customer lists and technology related to these product lines. As these product lines were considered a business, goodwill was allocated to the transaction. As these product lines did not have cash flows that were clearly distinguishable, both operationally and for financial reporting purposes, from the rest of the Company, they were not considered discontinued operations. This transaction closed in the first quarter of 2013 and no additional loss on sale was recognized. During the first quarter of 2013, the Company received $1.8 million in connection with this transaction and the third party assumed $2.4 million of severance liabilities. |
Restructuring Initiation Date | 2010 |
Restructuring And Related Activities Capital Expenditures Incurred To Date | 21,200,000 |
Restructuring and Related Cost, Cost Incurred to Date | 35,800,000 |
Liabilities Assumed By Third Parties | (2,398,000) |
Orthopaedic Facility Optimization [Member] | Severance And Retention [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Liabilities Assumed By Third Parties | (2,398,000) |
Orthopaedic Facility Optimization [Member] | Accelerated Depreciation And Asset Write Offs [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Liabilities Assumed By Third Parties | 0 |
Orthopaedic Facility Optimization [Member] | Other Restructuring [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Liabilities Assumed By Third Parties | 0 |
Orthopaedic Facility Optimization [Member] | Minimum [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring And Related Activities Expected Capital Expenditures | 25,000,000 |
Restructuring and Related Cost, Expected Cost | 36,000,000 |
Orthopaedic Facility Optimization [Member] | Minimum [Member] | Severance And Retention [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 12,000,000 |
Orthopaedic Facility Optimization [Member] | Minimum [Member] | Accelerated Depreciation And Asset Write Offs [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 15,000,000 |
Orthopaedic Facility Optimization [Member] | Minimum [Member] | Other Restructuring [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 9,000,000 |
Orthopaedic Facility Optimization [Member] | Maximum [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring And Related Activities Expected Capital Expenditures | 30,000,000 |
Restructuring and Related Cost, Expected Cost | 40,000,000 |
Orthopaedic Facility Optimization [Member] | Maximum [Member] | Severance And Retention [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 13,000,000 |
Orthopaedic Facility Optimization [Member] | Maximum [Member] | Accelerated Depreciation And Asset Write Offs [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 16,000,000 |
Orthopaedic Facility Optimization [Member] | Maximum [Member] | Other Restructuring [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 11,000,000 |
Medical Device Facility Optimization [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Activities, Description | Near the end of 2011, the Company initiated plans to upgrade and expand its manufacturing infrastructure in order to support its medical device strategy. This includes the transfer of certain product lines to create additional capacity for the manufacture of medical devices, expansion of two existing facilities, as well as the purchase of equipment to enable the production of medical devices. These initiatives are expected to be completed over the next two years. |
Restructuring Initiation Date | 2011 |
Restructuring And Related Activities Capital Expenditures Incurred To Date | 10,300,000 |
Restructuring and Related Cost, Cost Incurred to Date | 1,600,000 |
Medical Device Facility Optimization [Member] | Other Restructuring [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 1,000,000 |
Medical Device Facility Optimization [Member] | Minimum [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring And Related Activities Expected Capital Expenditures | 15,000,000 |
Restructuring and Related Cost, Expected Cost | 2,000,000 |
Medical Device Facility Optimization [Member] | Minimum [Member] | Production Inefficiencies, Moving And Revalidation [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 500,000 |
Medical Device Facility Optimization [Member] | Minimum [Member] | Personnel [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 1,000,000 |
Medical Device Facility Optimization [Member] | Maximum [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring And Related Activities Expected Capital Expenditures | 20,000,000 |
Restructuring and Related Cost, Expected Cost | 3,000,000 |
Medical Device Facility Optimization [Member] | Maximum [Member] | Production Inefficiencies, Moving And Revalidation [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 1,000,000 |
Medical Device Facility Optimization [Member] | Maximum [Member] | Personnel [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 1,500,000 |
ERP System Upgrade [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Activities, Description | In 2011, the Company initiated plans to upgrade its existing global ERP system. This initiative is expected to be completed over the next year. |
Restructuring Initiation Date | 2011 |
Restructuring And Related Activities Capital Expenditures Incurred To Date | 3,000,000 |
Restructuring and Related Cost, Cost Incurred to Date | 5,300,000 |
ERP System Upgrade [Member] | Minimum [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring And Related Activities Expected Capital Expenditures | 4,000,000 |
Restructuring and Related Cost, Expected Cost | 6,000,000 |
ERP System Upgrade [Member] | Minimum [Member] | Training And Consulting Costs [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 4,000,000 |
ERP System Upgrade [Member] | Minimum [Member] | Accelerated Depreciation And Asset Write Offs [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 2,000,000 |
ERP System Upgrade [Member] | Maximum [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring And Related Activities Expected Capital Expenditures | 5,000,000 |
Restructuring and Related Cost, Expected Cost | 7,000,000 |
ERP System Upgrade [Member] | Maximum [Member] | Training And Consulting Costs [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | 4,500,000 |
ERP System Upgrade [Member] | Maximum [Member] | Accelerated Depreciation And Asset Write Offs [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Restructuring and Related Cost, Expected Cost | $ 2,500,000 |

X
- Definition Amount of liabilities assumed by third parties during the period + References No definition available. + Details
Name: | gb_LiabilitiesAssumedByThirdParties
Namespace Prefix: | gb_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Total capital expenditures incurred to date in connection with restructuring and related activities + References No definition available. + Details
Name: | gb_RestructuringAndRelatedActivitiesCapitalExpendituresIncurredToDate
Namespace Prefix: | gb_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Expected capital expenditures in connection with a restructuring and related activities + References No definition available. + Details
Name: | gb_RestructuringAndRelatedActivitiesExpectedCapitalExpenditures
Namespace Prefix: | gb_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Initiation date of restructuring + References No definition available. + Details
Name: | gb_RestructuringInitiationDate
Namespace Prefix: | gb_
Data Type: | invest:dateStringItemType
Balance Type: | na
Period Type: | duration

X
- Definition This element represents the cash inflow during the period from the sale of a component of the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3179-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15, 16 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. + Details
Name: | us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Description of a specific restructuring plan and related activities including the facts and circumstances leading to the restructuring or decision to exit an activity, and the expected completion date. This concept and related items would be utilized for each plan if multiple exit plans have been implemented in the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 146 -Paragraph 20 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 95-3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of costs incurred to date for the specified type of restructuring cost. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=6394695&loc=d3e140904-122747 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 146 -Paragraph 20 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 95-3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 + Details
Name: | us-gaap_RestructuringAndRelatedCostCostIncurredToDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount expected to be charged against earnings in the current and future periods for the specified restructuring cost. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=6394695&loc=d3e140904-122747 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 146 -Paragraph 20 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 95-3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 + Details
Name: | us-gaap_RestructuringAndRelatedCostExpectedCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_RestructuringCostAndReserveLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration